GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Reshape Lifesciences Inc (STU:24O0) » Definitions » Shiller PE Ratio

Reshape Lifesciences (STU:24O0) Shiller PE Ratio : (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Reshape Lifesciences Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Reshape Lifesciences Shiller PE Ratio Historical Data

The historical data trend for Reshape Lifesciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reshape Lifesciences Shiller PE Ratio Chart

Reshape Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Reshape Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Reshape Lifesciences's Shiller PE Ratio

For the Medical Devices subindustry, Reshape Lifesciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Reshape Lifesciences's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Reshape Lifesciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Reshape Lifesciences's Shiller PE Ratio falls into.



Reshape Lifesciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Reshape Lifesciences's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Reshape Lifesciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.7762*131.7762
=0.000

Current CPI (Mar. 2024) = 131.7762.

Reshape Lifesciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.048 100.560 -5.305
201409 -3.104 100.428 -4.073
201412 -3.649 99.070 -4.854
201503 -68.376 99.621 -90.446
201506 -66.379 100.684 -86.878
201509 -26.730 100.392 -35.086
201512 -2.905 99.792 -3.836
201603 -2,969.686 100.470 -3,895.017
201606 -1,511.220 101.688 -1,958.369
201609 -524.353 101.861 -678.348
201612 -125.610 101.863 -162.497
201703 -59.372 102.862 -76.061
201706 -608.760 103.349 -776.205
201709 -659.992 104.136 -835.173
201712 -19.012 104.011 -24.087
201803 -74,671.852 105.290 -93,456.355
201806 -156,372.368 106.317 -193,818.441
201809 -1,176.592 106.507 -1,455.747
201812 -321.945 105.998 -400.241
201903 -2,883.330 107.251 -3,542.681
201906 -6,648.120 108.070 -8,106.487
201909 -4,832.376 108.329 -5,878.295
201912 -57.567 108.420 -69.968
202003 -28.507 108.902 -34.495
202006 -23.088 108.767 -27.972
202009 -56.034 109.815 -67.240
202012 -1.138 109.897 -1.365
202103 -52.080 111.754 -61.411
202106 -35.690 114.631 -41.028
202109 -44.200 115.734 -50.327
202112 -90.999 117.630 -101.943
202203 -19.858 121.301 -21.573
202206 -23.130 125.017 -24.381
202209 -27.280 125.227 -28.707
202212 -33.144 125.222 -34.879
202303 -1.457 127.348 -1.508
202306 -0.997 128.729 -1.021
202309 -0.956 129.860 -0.970
202312 0.000 129.419 0.000
202403 0.000 131.776 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Reshape Lifesciences  (STU:24O0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Reshape Lifesciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Reshape Lifesciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Reshape Lifesciences (STU:24O0) Business Description

Traded in Other Exchanges
Address
1001 Calle Amanecer, San Clemente, CA, USA, 92673
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Reshape Lifesciences (STU:24O0) Headlines

No Headlines